AI can improve the clinical trial process by simulating patient eligibility before recruitment begins. Determining whether patients meet complex inclusion and exclusion criteria is one of the most time-consuming aspects of clinical research. Generative AI can analyze large volumes of clinical data and model how different patient populations might qualify for a study, helping researchers evaluate trial feasibility earlier in the design process. Similar AI-powered eligibility and matching systems are already being developed to accelerate screening and improve recruitment efficiency.
A key benefit is the ability to create synthetic or simulated patient cohorts that reflect real-world characteristics while preserving privacy. Researchers can test eligibility rules against these virtual populations to estimate enrollment rates, identify overly restrictive criteria, and assess whether a trial is likely to attract enough participants. This allows study designers to optimize protocols before launching costly recruitment efforts.
The article also highlights how large language models can interpret complex eligibility requirements written in natural language. Clinical trial criteria often contain detailed medical conditions, treatment histories, laboratory thresholds, and timing requirements that are difficult to evaluate manually. AI systems can extract and structure these requirements, compare them against patient records, and provide explainable assessments of eligibility. Recent research has shown that AI-assisted screening can achieve high accuracy while dramatically reducing review time.
Ultimately, the author argues that generative AI could make clinical trials faster, more efficient, and more inclusive. By simulating eligibility outcomes, identifying recruitment challenges early, and supporting patient-to-trial matching, AI has the potential to reduce delays and costs while helping more suitable participants gain access to research opportunities. However, human oversight, regulatory compliance, and rigorous validation remain essential when applying AI to healthcare and clinical research workflows.
